Literature DB >> 23395260

Autophagy in Mycobacterium tuberculosis infection: a passepartout to flush the intruder out?

Delia Goletti1, Elisa Petruccioli, Alessandra Romagnoli, Mauro Piacentini, Gian Maria Fimia.   

Abstract

Tuberculosis is a global health calamity. The causative agent, Mycobacterium tuberculosis (M. tuberculosis), has evolved elaborate survival mechanisms in humans, allowing it to remain in a clinically latent infection state, constantly engaging the immune system, with the possibility to progress to active disease. Autophagy is a cellular process responsible for the degradation of intracellular components, including invading pathogens, playing an important role in both innate and adaptive immunity. In this review, we describe the molecular mechanisms employed by M. tuberculosis to avoid autophagic degradation and exploit this process to its own advantage. Moreover, we discuss the multiple roles played by autophagy in the immune responses to M. tuberculosis, and its unforeseen contribution to the antibacterial activity of tuberculosis-specific drugs.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-tuberculosis drugs; Autophagy; Autophagy gene polymorphisms; Inflammatory cytokines; Mycobacterium tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 23395260     DOI: 10.1016/j.cytogfr.2013.01.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  16 in total

Review 1.  Autophagy and checkpoints for intracellular pathogen defense.

Authors:  Geraldine L C Paulus; Ramnik J Xavier
Journal:  Curr Opin Gastroenterol       Date:  2015-01       Impact factor: 3.287

2.  IL17A augments autophagy in Mycobacterium tuberculosis-infected monocytes from patients with active tuberculosis in association with the severity of the disease.

Authors:  Nancy Liliana Tateosian; Joaquín Miguel Pellegrini; Nicolás Oscar Amiano; Agustín Rolandelli; Nicolás Casco; Domingo Juan Palmero; María Isabel Colombo; Verónica Edith García
Journal:  Autophagy       Date:  2017-06-05       Impact factor: 16.016

3.  IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis.

Authors:  Ana I Rovetta; Delfina Peña; Rodrigo E Hernández Del Pino; Gabriela M Recalde; Joaquín Pellegrini; Fabiana Bigi; Rosa M Musella; Domingo J Palmero; Marisa Gutierrez; María I Colombo; Verónica E García
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

4.  Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles.

Authors:  Leon J Khoza; Pradeep Kumar; Admire Dube; Patrick H Demana; Yahya E Choonara
Journal:  Int J Pharm       Date:  2022-06-06       Impact factor: 6.510

5.  Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosis.

Authors:  Giovanni Piccaro; Donatella Pietraforte; Federico Giannoni; Alessandro Mustazzolu; Lanfranco Fattorini
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

Review 6.  Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis.

Authors:  Anuradha Gupta; Amit Misra; Vojo Deretic
Journal:  Adv Drug Deliv Rev       Date:  2016-01-29       Impact factor: 15.470

7.  Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level.

Authors:  Sary El Daker; Alessandra Sacchi; Massimo Tempestilli; Claudia Carducci; Delia Goletti; Valentina Vanini; Vittorio Colizzi; Francesco Nicola Lauria; Federico Martini; Angelo Martino
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

8.  Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.

Authors:  Bindu Singh; Mohd Saqib; Ananya Gupta; Pawan Kumar; Sangeeta Bhaskar
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

Review 9.  Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics.

Authors:  Fabrizio Cantini; Carlotta Nannini; Laura Niccoli; Linda Petrone; Giuseppe Ippolito; Delia Goletti
Journal:  Mediators Inflamm       Date:  2017-06-01       Impact factor: 4.711

10.  Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy.

Authors:  Alessandra Romagnoli; Elisa Petruccioli; Ivana Palucci; Serena Camassa; Elisabetta Carata; Linda Petrone; Stefania Mariano; Michela Sali; Luciana Dini; Enrico Girardi; Giovanni Delogu; Delia Goletti; Gian Maria Fimia
Journal:  Cell Death Dis       Date:  2018-05-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.